❝ Executives from seven drugmakers laid out their ideas for lowering drug prices to the Senate Finance Committee on Tuesday. One idea was noticeably absent: lowering drug prices.
❝ The companies — AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi — threw their support behind a number of Trump administration proposals and pitched some of their own ideas in written testimony submitted ahead of the hearing. Executives championed the investments their companies make and the lives they save, while acknowledging patients cannot benefit if they can’t afford medication…
❝ But none of the seven drugmakers committed to, or even suggested, lowering the price of their drugs…
RTFA if you feel the need to read the sort of specious rationales you would expect from corporate royalty. You might wish to send a message to your Congress-critter to take the side of working families, ordinary Americans, instead of these high-priced pimps.
